Nat Med (2022) 28:5918
First, a brief context: stacking means combining two or more peptides to aim for additive or synergistic effects on muscle growth, fat loss, recovery, or metabolic function
The Treat and Reduce Obesity Act, HR4818, was introduced in 2023 with 65 cosponsors from across the aisle
In seven large cardiovascular studies, all agents shown at least non-inferiority, with liraglutide, subcutaneous semaglutide, and dulaglutide revealing statistically significant decreases in cardiovascular outcomes (Sheahan et al
Neuropsychiatric safety with liraglutide 3.0 mg for weight management: results from randomized controlled phase 2 and 3a trials
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy